One Year Post Exclusivity Adverse Event Review: Alendronate Pediatric Advisory Committee Meeting Sep - PowerPoint PPT Presentation

1 / 18
} ?>
View by Category
About This Presentation
Title:

One Year Post Exclusivity Adverse Event Review: Alendronate Pediatric Advisory Committee Meeting Sep

Description:

... glucocorticoid tx), fibrous dysplasia, osteogenesis imperfecta ... Indication: Treatment of severe Osteogenesis Imperfecta (OI) in patients 4-18 years ... – PowerPoint PPT presentation

Number of Views:158
Avg rating:3.0/5.0
Slides: 19
Provided by: SAC8
Category:

less

Write a Comment
User Comments (0)
About PowerShow.com